|
HS Code |
961302 |
| Product Name | Gastrointestinal Health Bacteria |
| Category | Probiotics |
| Primary Function | Supports digestive health |
| Form | Capsule |
| Serving Size | 1 capsule |
| Active Ingredient | Lactobacillus acidophilus |
| Shelf Life | 24 months |
| Storage Instructions | Keep in a cool, dry place |
| Manufacturer | HealthPlus Naturals |
| Country Of Origin | USA |
As an accredited Gastrointestinal Health Bacteria factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White and blue box containing 30 capsules; label reads "Gastrointestinal Health Bacteria" with clear dosage instructions and supplement facts displayed. |
| Shipping | **Gastrointestinal Health Bacteria** are shipped in temperature-controlled packaging to ensure product stability and viability. The shipment is handled via express delivery, typically dispatched within 24 hours of order confirmation. Proper documentation and labeling ensure compliance with relevant transport regulations. Refrigeration upon receipt is recommended to maintain quality. |
| Storage | Gastrointestinal Health Bacteria should be stored in a cool, dry place away from direct sunlight and moisture. Ideally, refrigeration (2-8°C) helps maintain its potency and viability. Ensure the container is tightly sealed to protect against contamination. Avoid exposure to heat and humidity, as these conditions can degrade the bacteria and reduce effectiveness. Always follow manufacturer storage guidelines. |
|
Purity 99%: Gastrointestinal Health Bacteria with a purity of 99% is used in probiotic supplement manufacturing, where it ensures high bioactivity and effective gut flora modulation. Colony Forming Units 1x10¹⁰ CFU/g: Gastrointestinal Health Bacteria containing 1x10¹⁰ CFU/g is utilized in fermented dairy products, where it significantly boosts intestinal microbial balance and resilience. Moisture Content <5%: Gastrointestinal Health Bacteria with moisture content below 5% is used in encapsulated probiotic formulations, where it enhances shelf life and stability during storage. Particle Size <100 µm: Gastrointestinal Health Bacteria of particle size less than 100 µm is applied in powder drink mixes, where it improves dispersion and intestinal absorption rates. Survival Rate 90% at pH 2.0: Gastrointestinal Health Bacteria with a survival rate of 90% at pH 2.0 is administered in functional foods, where it maximizes delivery to the intestines and supports improved digestive function. Stability Temperature up to 40°C: Gastrointestinal Health Bacteria stable up to 40°C is employed in heat-processed food production, where it maintains viability and efficacy after processing. Lactase Activity ≥100 U/g: Gastrointestinal Health Bacteria exhibiting lactase activity of 100 U/g or higher is used in lactose-free dairy applications, where it aids in efficient lactose hydrolysis and supports lactose intolerance management. Capsule Formulation: Gastrointestinal Health Bacteria in a specialized capsule formulation is administered in clinical nutrition products, where it enhances targeted delivery and protection against gastric degradation. |
Competitive Gastrointestinal Health Bacteria prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturing bacteria cultures for gut health isn’t a simple add-on to our facility—it’s the result of decades growing live strains, monitoring fermentation every shift, and investing in tools that let us see what’s really happening at the cellular level. This is our bread and butter, not a sideline. We work with food and feed producers who come to us because they need the real thing, grown in controlled conditions, batch after batch, not somebody’s surprise mix from an unknown warehouse.
Gut health needs more than generic promises. Most suppliers sell on buzzwords but leave out how their bacteria actually behave in a real digestive environment. We select strains based on vigorous acid and bile tolerance, ability to survive typical processing, and proven metabolic activity that supports both short-chain fatty acid production and microbial balance. Our leading model, GH-220, often forms the backbone of custom blends for customers who want tangible probiotic activity, starting from at least 2x1010 CFU/g in powder form, with rigorous controls throughout production to limit contaminants and preserve shelf stability.
We invested in real-time qPCR and flow cytometry so that we know how many viable bacteria are making it through—not just the number on a theoretical certificate, but actual activity under simulated GI tract stress. We release these data for audits by our direct customers so nobody relies on marketing, but on hard analysis. That is a direct result of years scrapping with quality control failures in earlier decades—there’s no shortcut to getting consistently strong yields with demanding strains.
Our fermentation vessels run on programmable logic controllers, linked right back to in-house bioprocess engineers who have practical mastery of upstream conditions. When we transitioned to a semi-continuous process, it gave us much tighter controls and rendered off-spec lots nearly extinct. These engineering tweaks come from chemists and process managers sitting down together, mapping out what actual improvements are possible, not just tackling paperwork.
The biggest difference in our product lines comes down to details. In the GH-220 production run, each batch starts with a certified mother culture stored under deep freeze. The medium contains only non-GMO sugars, plant-based proteins, and no porcine inputs, because our partners told us that’s what they and their end users demanded. We harvest by centrifuge, lyophilize for powder stability, and add a customized cryoprotectant so the vast majority of the bacteria survive the drying process. It’s not just a question of numbers—it’s about guaranteeing activity for at least 24 months from leaving our cleanroom, even if it sees routine temperature swings in shipping warehouses.
Customers ask about water dispersion and taste neutrality, and we deliver on that because the post-processing minimizes flavor and odor. This has been a frustration for many, especially those making chewables or functional foods. Years spent trialing different excipients and drying processes paid off: GH-220 doesn’t clump or sour a finished product when used at the common inclusion rates. Our routine partners range from dairy product makers to nutritionists formulating capsules and granules—each comes with a list of real-world issues we’ve built solutions around, whether it’s shear stability in mixing or resistance to common beverage acidification.
One reason manufacturers stick with us is that we operate out of our own facility and understand what it means to have someone’s entire production run relying on the quality of our cultures. We send more than a certificate—we send actual samples from pilot runs, not just the final blend, because issues often show up only at scale. Any production delay on our side flows downstream—and we’ve built our process so that’s not the norm. Turnaround remains tight, and our bulk packaging is designed around the demands of material handlers, not just what looks good in a spec sheet.
Dosage really varies by application. Standard recommendation from our R&D is 1-5 billion CFU per serving for functional food formats, and 10-50 billion when used in clinical nutrition, but the actual viability after processing serves as our guiding light. We track survival during extrusion, heating, freeze-drying, and shipping. This gives each customer a map—what survives through their own process so that the finished product on the shelf isn’t a guess, but an assurance. We never stopped after the lab validation: field trials in full-scale food factories covered everything from baked goods to ready-to-drink beverages, and the product modifications over the years bear witness to every complaint or complaint resolved.
We don’t compete with anonymous blends out of Asia, where paperwork often means little and even simple tracebacks break down under scrutiny. We have full audit trails from seed culture to pallet, maintained by veteran staff who understand the stakes when something goes wrong. In our industry, stories abound of relabeling and fake documentation—years of side-by-side testing against these mystery powders convinced us to focus on unbreakable chain-of-custody, real species identification, and open quality control results shared directly with our customers. The resources we pour into documentation aren’t just for show; they’re the difference between being trusted by pharmaceutical partners and being replaced by the next cheapest option.
The biggest issue in the market: too many blends from resellers rely on bulk-purchased freeze-dried powder with uneven mixing and poor microbial consistency. We routinely run internal side-by-side assays comparing our batches with competitor samples sourced from retail, and nearly all of the third-party products fail to match their stated cell count or even contain the advertised strains in meaningful ratios. Our process avoids bulk “white label” intermediaries entirely, a practice that became our core principle after seeing how many failures happen at that exchange. Individual batch analysis, including strain ratio verification by MALDI-TOF MS, cuts out 90 percent of the phantom issues that surface only after six months in customer storage.
The difference between a producer and a reseller sits in the willingness to tailor—not by stirring in a scoopful of something from another drum, but by rewriting bioprocess settings, upstream nutrition, and viable-count tracking to match what the real-world customer’s process actually needs. We’ve built custom runs for everything from non-dairy vegan yogurts, where residual animal protein triggers allergen controls, to pelleted feed for livestock with specific requirements on heat resistance and GI tract delivery. This wasn’t an afterthought; our plant’s modular bioreactor systems were designed for both flexibility and dialing in on clean transitions between production campaigns, eliminating cross-batch contamination as a matter of engineering design.
We work hands-on with development teams at both big and small manufacturers, running onsite audits, troubleshooting tricky blending or extrusion machinery, and helping solve stability issues not just with words on an email, but by sending technical staff to the production floor when needed. Every failure learned the hard way—be it a spoiled yogurt lot or a batch of supplements failing label claims—taught us where the limits of textbook procedures end and practical solutions must start.
Consumer trust in probiotic and functional food products sits at a low ebb, thanks to high-profile news of mislabeling, contamination, and vanishing viability in products that claim sky-high cell counts. We see this up close in every QA project we audit for new customers—mystery strains that weren’t advertised, wild swings in cell viability, and inconsistent toxin screening. Our approach remains to publish full safety screening data on every production lot, run authenticating DNA fingerprinting on every mother culture, and work tightly with regulatory auditors on site. Transparency is more than a bullet point; it’s a reality driven by too many years of being called in to remedy disasters caused by suppliers who cut corners.
Beyond the manufacturing floor, our QA works in lockstep with product managers to verify allergen profiles, permissible GMO status, and environmental impact for every input. Materials waste from failed fermentation campaigns is tracked and managed, not dumped or blended off spec. We also source all media ingredients directly, after learning from earlier supply chain disruptions: every sugar, protein, and salt has a verified origin and safety documentation, and substitution only happens after a fresh round of process validation.
While gut health bacteria manufacture isn’t as energy-intensive as classical chemical syntheses, water and energy usage still drive decisions. We reengineered our CIP (clean-in-place) systems to recirculate water, managed process waste for compositing rather than landfill, and fully automated all major fermentation so that downtime and spoiled lots went down year-on-year. These investments—prompted by both environmental goals and sheer economic sense—have changed our annual material cost structure, and each product batch reflects those savings and resource stewardship. Customers are asking harder questions about “green” processing, and we’re in a position to answer them with verifiable in-plant data, not slogans.
Shipping bulk powders or granulated blends also prompted us to rethink our container usage, driving us toward recyclable packaging and more efficient stackable drums that reduce breakage and loss in transit. Every failed shipment in years past—each tied to inferior packaging or interruptions in cold-chain integrity—revealed another place to improve, revise, and reinvest.
The regulatory landscape for gut health products shifts constantly. Rather than chase paperwork after changes, we assign a regulatory manager to every production campaign, keeping each dossier up to date with relevant food safety, labeling, and country-specific rules. We’ve had the odd product batch held at a border, or reviewed by local authorities who flagged wording or composition, and those events drove us to pre-clear every label and claim with the authorities where our customers sell. Our partners aren’t left alone to interpret flavor-of-the-month compliance reports—the manufacturer stands with them from planning to shipment.
We learned the hard way that only proactive safety screening, supported by unbroken supply chain documentation and direct-lot testing, provides enough peace of mind for large-scale launches. Every year, our plant receives site audits not just from domestic agencies, but also from multinationals with independent product stewardship staff. Passing these audits and building trust with these teams rested on never cutting corners or shortcutting any check, even in busy seasons where the temptation looms to move a batch out the door faster than is wise.
In food and supplement production, a product is only as trustworthy as the supply line from its source. Our traceability framework covers not just raw material receipt and culture progression, but also records on maintenance, operator sign-offs, and in-line monitoring during every campaign. Our decision to keep manufacturing and fulfillment in-house (rather than farming out to toll producers) lets us react immediately to any potential deviation, recalling or quarantining suspect batches in hours, not days.
If an end product gets flagged for review, our records allow tracking back to individual growth runs and even operator shifts, providing answers rather than guesses. It’s an approach born out of necessity—previous experiences of batch recalls and QA inconsistencies are not theoretical, but living reminders of the risks in ignoring detail.
This market fills with “high-count” blends every year, but count doesn’t mean much if the bacteria can’t withstand stomach acid or get wiped out by manufacturing heat. We run every batch through in vitro digestion simulation and independent viability testing before releasing a lot. Many companies post a headline species list; we release the underlying analytical data, with DNA and phenotype confirmation down to each strain. Our top performing model, GH-220, has held up in acid and bile challenges at rates exceeding most public benchmarks, and that’s measured in actual field samples, not just bench tests. The numbers on our spec sheets have real world backing drawn from hundreds of full-scale manufacturing cycles—not just a handful of lab experiments.
Every new production option, such as slow-release granulation for supplement blends, gets validated in actual plant machinery before it’s offered to the open market. Years back, we saw too many customer complaints stemming from theoretical improvements that failed to deliver on the production floor. Now, we spend months trialing new process tweaks internally, so partners can trust that ‘new and improved’ means more than a label design.
Customers who rely on us get more than a shipment—they get access to troubleshooting for their factory scenarios, rooted in our own daily challenges of live-culture manufacturing. We match expert microbiologists and engineers to customer projects, not junior reps who only read manuals. This connection brings depth to every troubleshooting session, whether it’s figuring out why a batch clumps during high-speed blending or pinpointing where viability loss creeps in during storage. Our team has handled it all, from unexpected shutdowns to supply chain snags, and the shared learning builds a stronger foundation for each production cycle.
Feedback doesn’t vanish into a suggestion box. Each actionable comment translates into weekly process meetings and long-view planning. Customers benefit from the steady focus on identification and resolution, not just apology emails or blame shifting. Building confidence takes persistence—and more than a little humility—after each lesson learned on the factory floor.
The past few years brought a surge of technical demands from end-users seeking products with both high resilience and more precise targeting—tougher bacteria able to deliver functional benefits well beyond generic gut support. Our team responded by selecting fresh strains from proprietary microbial libraries and pushing R&D budgets toward more robust, dual-layered encapsulation processes. Each innovation had to prove itself through full-scale fermentation, downstream recovery, and weeks of accelerated stability testing before a single customer ever received a sample.
We balance innovation with practicality. A promising discovery in the lab means nothing without process reliability and predictable upscaling. New production runs roll out only once the engineering and QA teams sign off side-by-side, ensuring that speed never eclipses safety. Our goal: give customers not only a story for marketing teams but a product line that operates smoothly in the toughest, most cost-driven industrial environments.
In our field, trust is earned batch by batch. Customers don’t return for vague assurances or clever ad copy—they come back after experiencing consistent, reliable results across production cycles. We built our ‘Gastrointestinal Health Bacteria’ line through years of direct manufacturer insight, not theory, responding to every operational headache, regulatory shuffle, and market shift with practical, science-based changes. The result is a product born not from what looks good on a web page, but from what keeps factories running and finished goods on shelves as promised.
Each order represents our commitment: live support for integration, robust supply chain guarantees, and the quiet confidence that comes from controlling every variable from fermentation to packaging. We don’t deal in impossible claims—just steady, evolutionary improvement through hands-on manufacturing expertise, technical transparency, and a willingness to back up every batch with comprehensive, open data and human accountability. Those who use our products see the impact, not just in headline claims, but where it matters—finished products, reliable delivery, and a solid connection with the people crazy enough to get up at 4 AM to check one more fermentation vessel because it just might make the difference in a thousand-ton run.